Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Hi-Tech Pharmaceuticals has received third-party independent GMP certification of its Georgia and Pennsylvania facilities.
read more
HiFiBiO SAS has announced that the company has achieved a milestone in its research collaboration with Pfizer triggering a milestone payment to HiFiBiO.
read more
Highmark announced an outcomes-based contract with Boehringer Ingelheim for Jardiance, an oral medicine indicated to lower blood sugar in adults with type 2 diabetes.
read more
Monday, September 23, 2019
Hikma Pharmaceuticals has launched a new prefilled syringe capability in the US through its affiliate, Hikma Pharmaceuticals USA Inc.
read more
Hikma and Civica Rx have announce a five-year agreement to manufacture and supply Civica's growing membership of US health systems with medications that are often in short supply in US hospitals.
read more
Harvest Integrated Research Organization (HiRO), announced its acquisition of DeltaMed Solutions, an emerging CRO with a robust foothold in the US. The acquisition, advised by Evercore as financial advisor, marks HiRO's third CRO acquisition since ...
read more
Friday, December 13, 2013
Okochi will have full profit and loss responsibility as well as overall accountability for all aspects of the Harlan Contract Research Services (CRS) business stream serving the Japanese chemical, agrochemical and pharmaceutical markets.
read more
Hitachi Chemical Advanced Therapeutics Solutions (HCATS) announced they have signed a three-year clinical manufacturing agreement with GSK, a science-led global healthcare company
read more
HitGen announced it has achieved a milestone in its discovery alliance with Merck & Co. Inc., Kenilworth NJ.
read more
HitGen has entered into a drug discovery research collaboration with Gilead Sciences to identify potential small molecule leads against targets of interest to Gilead.
read more
HitGen has extended and expanded its agreement with Merck into a multi-year research collaboration and license agreement to build and screen novel DNA-encoded libraries.
read more
HitGen announced the company has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest.
read more
Monday, November 27, 2017
HitGen announced the company has entered into a drug discovery research collaboration with Boehringer Ingelheim.
read more
Wednesday, March 11, 2020
HitGen and Kaken Pharmaceutical have entered into a license agreement to develop a novel class of drugs.
read more
In Sisseln, Switzerland, high-quality tablets, granules, effervescent tablets and hard capsules are produced by Aenova on a footprint of more than 6,000 m2 and a production area of more than 1,900 m2 by 160 employees - and with a completely CO2-free ...
read more